共 193 条
[21]
Slomski R(1998)Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis J Child Neurol 13 173-105
[22]
Kwiatkowski DJ(2010)The tuberous sclerosis complex Ann N Y Acad Sci 1184 87-1192
[23]
Hussain N(2011)Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis Expert Rev Anticancer Ther 11 1181-498
[24]
Curran A(2006)Rapamycin causes regression of astrocytomas in tuberous sclerosis complex Ann Neurol 59 490-1239
[25]
Pilling D(2008)Regression of subependymal giant cell astrocytoma with rapamycin in tuberous sclerosis complex J Child Neurol 23 1238-479
[26]
Malluci CL(2010)Rapamycin (sirolimus) in tuberous sclerosis associated pediatric central nervous system tumors Pediatr Blood Cancer 54 476-384
[27]
Ladusans EJ(2010)Rapamycin as an alternative to surgical treatment of subependymal giant cell astrocytomas in a patient with tuberous sclerosis complex J Neurosurg Pediatr 6 381-181
[28]
Alfirevic Z(2011)Regression of subependymal giant cell astrocytomas with RAD001 (everolimus) in tuberous sclerosis complex Childs Nerv Syst 27 179-75
[29]
Pizer B(2005)Effects of rapamycin in the Eker rat model of tuberous sclerosis complex Pediatr Res 57 67-1298
[30]
Louis DN(2011)Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma Eur J Cancer 47 1287-630